InvestorsHub Logo
Followers 8
Posts 273
Boards Moderated 0
Alias Born 03/22/2013

Re: tke458 post# 352927

Tuesday, 08/31/2021 8:43:22 AM

Tuesday, August 31, 2021 8:43:22 AM

Post# of 426856
Stillness's prediction is based on logical, big pharma strategy. There's a saying in the BIG pharma camp: "You live with what you launch with". If PFE is buying Amarin, they'll want to control the launch in whatever countries are left. That said, Germany may be too late, or not.

Aside from the DU decision and even COVID, the launch in the USA was/is a huge, miserable failure. From non existent marketing, to a meager 600 person sales force with reps who were under paid and under trained. They had no inkling of the underhanded tactics pharma and their paid, medical henchmen would throw at Vascepa. JL was right, it should have sold itself. But the "fish oil" comparison, mineral oil slinging, and other BS kept Amarin's head spinning, along with a novice management team (maybe inept as well) lead us to where we are now. Sure Covid and Du played a role, but this doesn't happen if PFE, BMS, Amgen, or whoever is in control.

So here we are....living with it! So, does this happen again when we launch in Europe? IF...PFE is in the picture, Vaskepa sells itself!

Web
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News